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Abstract
Background: Recent serological studies indicate that hepatitis E virus (HEV) is endemic in industrialised countries.
The increasing trend in the number of autochthonous cases of HEV genotype 3 in Western European countries,
stresses the importance to get insight in the exact routes of exposure. Pigs are the main animal reservoir, and
zoonotic food-borne transmission of HEV is proven. However, infected pigs can excrete large amounts of virus via
their faeces enabling environmental transmission of HEV to humans. This might pose a risk for of neighbouring
residents of livestock farming.
Methods: Within a large study on the health of people living in the vicinity of livestock farming we performed a
cross-sectional population-based serological survey among 2,494 non-farming adults from the general population in
a livestock-dense area in the south of the Netherlands. Participants completed risk factor questionnaires and blood
samples of 2,422 subjects (median age 58 years, range 20–72) were tested for anti-HEV IgG using an enzyme
immune assay (Wantai). The aim of this study was to determine the HEV seroprevalence and to assess whether
seropositivity in adults was associated with living in the vicinity of pig farms.
Results: The average seroprevalence of HEV was 28.7% (95% CI: 26.9–30.5). Determinants associated with an
increased risk for HEV seropositivity were male gender and low level of education. There was a clear trend of
increasing prevalence with increasing age (Chi-square test for linear trend, X2 = 83.1; p < 0.001). A high number of
pigs within 1,000 m of the residential address was not a risk factor for seropositivity.
Conclusions: This study confirmed the high HEV seroprevalence (29%) in the general population of the Netherlands,
but presence of antibodies was not associated with residential proximity to pig farms. The prevalence increased with
age from 10% in adolescents to 33% among those aged 50 and above, supporting the assumption of a cumulative
lifetime exposure to HEV in the Netherlands as well as a higher infection pressure in the past. Our findings cannot
refute the assumption that transmission is primarily food-borne.
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Background
Hepatitis E virus (HEV) is a major cause of enterically
transmitted hepatitis, especially in developing countries.
However, recent studies show that autochthonous HEV
infections are an increasing public health concern in
industrialised countries [1–12].
The most common clinical presentation of HEV in-
fection is acute hepatitis. Usually this is a self-limiting
disease, with jaundice as the most common symptom
[4, 13–15]. In patients with pre-existing liver disease
and immunosuppressed patients, the clinical course of
disease is often more severe and in developing countries
excess mortality is seen in pregnant women [8, 10, 14–16].
However, most HEV infections in industrialised countries
are either unrecognised or asymptomatic [1, 14, 16, 17].
This is supported by recent serological studies in several
European countries, showing that the anti-HEV IgG sero-
prevalence in healthy blood donors varied between 7 and
52%, depending on both geographical area and the anti-
body assay used [17–22].
HEV is a non-enveloped single-stranded RNA virus
belonging to the Hepeviridae family [16, 17, 23]. Four
major genotypes, within species Orthohepevirus A, can
infect humans [10, 15, 23, 24]. The genotypes 1 and 2
are restricted to human beings, and the genotypes 3 and 4
can infect both human beings and mammals. HEV-1 and
HEV-2 are endemic in developing countries, leading to
sporadic cases as well as large outbreaks. HEV-3 and
HEV-4 are responsible for an increasing number of au-
tochthonous hepatitis E infections worldwide [4, 10, 16,
17, 25]. The more recently discovered HEV genotypes 5
and 6 are so far only detected in animals, while genotype 7
is also described in humans [10, 26–29].
In contrast to HEV-1 and HEV-2, for which the faecal-
oral transmission route via contaminated water has been
confirmed, the transmission routes of HEV-3 and HEV-4
are largely unclear and the exact source of infection re-
mains unknown for the majority of patients [4, 17, 27, 28].
The increasing trend in the number of autochthonous
cases in Western European countries stresses the import-
ance to get insight in the route of infection, enabling
the implementation of control measures against hu-
man HEV infections [27, 28, 30].
It is hypothesized that HEV-3 and HEV-4 have a
zoonotic origin, supported by the high prevalence of
HEV-3 and HEV-4 among domestic pigs and wild
boars [23, 26, 31]. In the Netherlands, the prevalence
rate of HEV-3 in the domestic pig population is estimated
at 55%, and domestic pigs may therefore be an important
reservoir for human HEV infections [28, 32]. Furthermore,
the frequent detection of HEV in pork products and the
high similarity between porcine and human HEV sequences
suggest zoonotic transmission of HEV-3 and HEV-4 world-
wide [33–36]. Zoonotic food-borne transmission has been
proven by the identification of identical nucleotide se-
quences in autochthonous HEV patients and in leftover
portions of consumed contaminated food [37–40]. But
zoonotic HEV transmission might also occur through
exposure to contaminated environments. Infected pigs,
which are generally asymptomatic, can excrete large
amounts of virus via their faeces in the environment.
This may lead to human infections [26–28, 41]. The high
anti-HEV serum antibody rates in humans with occupa-
tional contact with pigs, like farmers and veterinarians,
provide indirect evidence for this route of transmission
[42–47]. However, environmental exposure to HEV might
also pose a risk for of neighbouring residents of livestock
farming, as was the case during the major Dutch Q-fever
outbreak in 2007–2010 [48].
In the Netherlands there is an ongoing debate on the
environmental health risks as a result of (intensive)
livestock farming in areas highly populated with both
livestock and people. At a surface of approximately
34.000 km2 almost 17 million people are living together
with 75 million chickens, 7 million pigs, 4 million cattle
and 1.5 million goats and sheep. Within a large study
on the health of people living in the vicinity of livestock
farming, we performed a serological survey in order to
assess the HEV seroprevalence among non-farming
adults from the general population in a livestock-dense
area in the south of the Netherlands. Furthermore, we
investigated whether living close to pig farms is a risk
factor for HEV seropositivity, focusing on the role of
environmental transmission of HEV from pig farms to
residents living in the vicinity of these farms.
Methods
In 2014 the Livestock Farming and Neighbouring Resi-
dents’ Health study (Dutch acronym: VGO) started, aim-
ing to assess the relationship between livestock farming
and a number of health outcomes in people living in the
eastern part of the province of Noord-Brabant and the
northern part of the province of Limburg. This part of
the Netherlands is a relatively highly populated rural
area with a high density of livestock farms. Within the
VGO study a cross-sectional health study was performed,
investigating three categories of health effects: 1) respira-
tory health effects, 2) livestock-associated infections, and
3) carriage of resistant microorganisms. Furthermore, air
sampling was conducted in order to assess to what extent
residents living in the vicinity of livestock farms were ex-
posed to emissions of these farms, including endotoxin
amount, PM10 and DNA of Staphylococcus aureus and E.
coli. Participants of the cross-sectional health study pro-
vided blood samples in order to assess (previous) exposure
to several livestock-farming associated pathogens, includ-
ing HEV.
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Study population
The study population was selected in a two-step proced-
ure. First, a questionnaire survey was conducted among
14,163 unrelated adults from the general population
(aged 18–70 years) living in the study area. Participants
were recruited via their general practitioner (GP). In the
Netherlands each individual is registered with just one
general practice, mostly close to residential address. Pre-
defined inclusion criteria have been described previously
by Borlée et al. [49]. Second, questionnaire participants
who gave consent to be contacted for further studies,
and who were not working or living on a farm, were eli-
gible for the serological survey (n = 8,714) [50]. Based on
their home addresses, twelve temporary study centres
were established. Figure 1 shows the location of the tem-
porary study centres, and pig density in the Netherlands
in 2014. All participants living within a distance of ap-
proximately 10 km of a temporary study centre (n = 7,180)
were invited to the nearest centre for a medical examin-
ation, including blood sampling for serological analyses
against livestock-associated pathogens. Furthermore, they
were asked to fill in a questionnaire comprising items on
symptoms and diseases, home characteristics, smoking
habits, education, profession, leisure activities, dietary
habits (including the consumption of pork meat), and ani-
mal contact, including exposure to animal farm environ-
ment during childhood. Data were collected between 10
March 2014 and 27 February 2015. Patients’ privacy was
ensured as described earlier [49–51]. In short, medical in-
formation and address records were kept separated at all
times by using a Trusted Third Party (Stichting Informatie
Voorziening Zorg, Houten). The VGO study protocol was
approved by the Medical Ethical Committee of the Uni-
versity Medical Centre Utrecht. All participants signed
informed consent.
Exposure from livestock farms
Based on the home address of each participant, several
exposure variables were computed, including distance to
the nearest pig farm with more than 25 pigs and the
total number of pigs within 1,000 m [52]. Information
on farm characteristics in the study area was derived
from the provincial database of mandatory environmental
licenses for keeping livestock for 2012. This database con-
tains amongst others data on number and type of animals
and geographic coordinates of farms (specific for type of
livestock).
Fig. 1 Location of temporary study centres in relation to pig density in the Netherlands in 2014 (Source: Statistics Netherlands)
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Serological analyses
Sera were analysed at the National Institute for Public
Health and the Environment (RIVM) for the presence of
IgG antibodies against HEV, using a commercial anti-HEV
IgG enzyme immune assay (Wantai Biological Pharmacy
Enterprise Co,. Ltd., Beijing, China). The test was per-
formed according to the instructions of the manufacturer.
Samples with anti-HEV IgG ratio <0.90 were considered
negative, those with ratio > =0.90 but <1.10 were defined
as borderline, and samples with ratio > =1.10 were consid-
ered as positive.
Statistical analyses
Seroprevalence, defined as the percentage of participants
with borderline or positive anti-HEV IgG ratio, and 95%
confidence intervals (CI) were calculated for the overall
study population, per age group and per study centre.
Logistic regression analysis was performed to study
potential determinants for HEV seropositivity. The fol-
lowing variables were included in the univariate analysis:
age, gender, educational level, country of birth, con-
sumption of pork meat, smoking status, spending child-
hood in the study region or on a (pig) farm, performing
jobs on a farm during childhood, contact with animals
during work or study, keeping farm animals and/or pigs
for a hobby in the last 5 years, spending time abroad
during the last 12 months, visiting a farm in the last
12 months (with or without contact with pigs during
that visit) and the numbers of pigs within 1.000 m of the
residential address of the participants. All variables with
a P-value < =0.2 in the univariate analyses were included
in the multivariate logistic regression model. Adjusted
odds ratios (ORs) and 95% CIs were calculated and a P-
value <0.05 was used to determine significance. T rend
in seroprevalence with increasing age was tested with
the Mantel-Haenszel chi square for linear trend.
Median distance from home address to nearest farm
with more than 25 pigs was compared between partici-
pants with positive or borderline and those with negative
anti-HEV IgG ratio using Mann-Whitney U test. This
analysis was stratified by six age groups: 20–29, 30–39,
40–49, 50–59, 60–69 and 70 years and older.
The random forest method (46) was used to determine
the ability of the potential risk factors to predict the
anti-HEV IgG ratio or the infection status. Unlike regres-
sion, the random forest requires no underlying assumptions
about the functional form of the model or distribution of
the data and provides a reliable assessment of the contribu-
tion of the predictor variables to generate predictions of an
outcome. The algorithm predicts the outcome (e.g. anti-
HEV IgG ratio) of an individual based upon the individual’s
predictor variables, quantifies the prediction accuracy by
means of estimates such as the mean square error (or pro-
portion of correct classifications/statuses when predicting
the status of an individual) and proportion of explained
variance, and ranks the predictor variables according to
their relative importance. Relative importance of a predictor
variable is calculated by randomly permuting the data for
that variable (leaving all other data unchanged) and com-
paring the prediction accuracy obtained with the ‘shuffled’
data set with that of the original data set. If the variable has
little bearing on prediction, the mean square error will re-
main about the same after shuffling, while if the variable is
useful for prediction the mean square error will deteriorate.
The increase in mean square error that results from the
shuffling is then a measure of variable importance which is
used to rank the predictor variables.
Analyses were performed using SAS 9.3 and R version
3.1.0 (Random forest).
Results
A total of 2,494 of the 7,180 invited persons participated
in the cross sectional serological survey, (response rate =
34.7%). Serum samples were available for 2,422 partici-
pants (97.1%). The primary reason for missing serum-
samples was failure to collect enough blood for analysis.
The median age of the participants, from whom a sample
was available, was 58 years (range: 20–72 years) and 45.6%
was male (Table 1). Although there were some differences
between responders and non-responders, a non-response
analysis within the initial questionnaire survey comparing
the electronical medical records of the subjects recruited
via GPs, showed that these differences do not affect the re-
lationship between health and the presence of livestock
[53]. A total of 2,163 of the 2,422 participants (89.3%) re-
sided in the province of Brabant and Limburg during
childhood, of which 1,816 (84.0%) lived in the specific
study region. On average, the participants have lived at
their current residential address for 20 years (standard de-
viation 13.5 years). The number of pigs within 1,000 m of
the residential address varied between 0 and 79,057
(median = 2,701; interquartile range: 336–9,035) and
the distance to the nearest pig farm with more than 25 pigs
ranged from 11 to 2500 m (median = 687 m; interquartile
range: 462–932).
Positive and borderline positive anti-HEV IgG ratio
was found for respectively 666 (27.5%) and 29 (1.2%) of
the 2,422 participants. Overall seroprevalence was 28.7%
(95% CI: 26.9–30.5; Table 1), ranging between study cen-
tres from 16.7% (95% CI: 8.1–25.3) to 35.7% (95% CI:
25.5–46.0). Seroprevalence increased with age (Fig. 2).
Multivariate logistic regression analysis showed an in-
creased risk for HEV seropositivity in participants aged
50 years or older, male participants and participants who
reported a low level of education (Table 2). There was a
clear trend of increasing prevalence with increasing age
(Chi-square test for linear trend, X2 = 83.1; p < 0.001). A
high number of pigs within 1,000 m of residential address
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was not a risk factor. Other variables for exposure to pigs
(e.g. number of pig farms or the presence of at least one
pig farm within 1,000 m of residential address) gave
similar results in both univariate and multivariate logistic
regression analyses as number of pigs within 1,000 m of
residential address (data not shown). Participants who re-
ported to follow a diet without pork meat (n = 47) did not
have a significantly lower risk for HEV seropositivity.
Exclusion of the 29 samples with borderline positive
anti-HEV IgG ratio did not affect the results of the of
univariate and multivariate logistic regression analyses.
This also holds when the borderline samples were consid-
ered as negative anti-HEV IgG ratio (data not shown).
Generally, seronegative participants lived closer to pig
farms than seropositive participants. This difference was
statistically significant for the overall group and for the
age group 60–70 years (Table 3).
Despite the associations detected and reported above,
the random forest method showed that the potential risk
factors considered in this study are not at all able to pre-
dict anti-HEV IgG ratio nor disease status (results are
omitted). Indeed, the proportion of explained variance
was practically zero in our prediction analysis, which in
particular prevents us from ranking the risk factors.
Discussion
The present population-based serological survey con-
firms the high HEV seroprevalence (29%) in the general
population of the Netherlands, but provides no evidence
for environmental transmission from pig farms to humans
living in the vicinity of these farms.
Comparison of the seroprevalence found in this study
with results from other European countries is difficult
because of considerable differences in the studied popu-
lations, as well as the used assay for HEV antibody test-
ing [54–56]. Recent studies using sensitive assays (like
the Wantai assay we used) reported HEV seroprevalence
varying between 16% and 52% [18, 57–61]. Our sero-
prevalence (29.7%) corresponds well with the 27% preva-
lence found in a large serological screening of Dutch
blood donors [18]. Both studies used the Wantai assay
to measure HEV specific IgG antibodies. In contrast, a
population-based seroprevalence study in the general
population in the Netherlands in 2006–2007, using a less
sensitive assay for detection of prolonged IgG antibodies
(MP Diagnostics, France), found a seroprevalence of
only 3% [62]. Comparative studies suggest that the Wan-
tai assay gives the most reliable estimate of the HEV
seroprevalence, because it is more sensitive, it is positive
Fig. 2 Seroprevalence of antibodies against hepatitis E virus by
age group
Table 1 Density of pigs, details of study population and hepatitis E virus seroprevalence by study centre
Study centre Density of pigsa Number of
participants
Median age (years) Range (years) Male participants (%) Seroprevalenceb (%) [95% CI]c
Afferden 717 49 59.2 [33.5–71.1] 57.5 25.5 [13.1–38.0]
Astend 3,535 291 61.4 [20.4–71.4] 45.8 34.0 [28.6–39.5]
Bakel 3,756 315 59.3 [21.5–71.7] 47.1 29.2 [24.1–34.3]
Boxtel 988 170 59.3 [24.8–71.6] 45.0 27.2 [20.5–33.9]
Budel 1,080 200 61.4 [21.4–71.6] 49.5 32.6 [25.8–39.4]
Deurne 3,882 132 60.5 [29.0–71.7] 50.0 18.6 [11.7–25.4]
Heeswijk-Dinther 3,812 375 57.5 [20.1–71.4] 37.1 30.1 [25.5–34.8]
Heusdend 3,535 72 58.9 [24.2–71.4] 55.6 16.7 [8.1–25.3]
Horn 1,268 85 57.1 [24.0–71.7] 45.2 35.7 [25.5–46.0]
Someren 3,447 170 57.9 [28.6–71.2] 48.2 29.4 [22.6–36.3]
St. Anthonis 4,460 399 57.0 [22.6–71.8] 44.5 26.9 [22.4–31.4]
Stramproy 878 236 57.4 [21.3–72.0] 46.3 26.6 [20.9–32.4]
Total 2,506 2,494 58.6 [20.1–72.0] 45.6 28.7 [26.9–30.5]
aNumber of pigs per km2 by municipality, based on the provincial databases of mandatory environmental licenses for keeping livestock for 2012
bAnti-HEV IgG ratio > = 0.90
c95% Confidence Interval
dAsten and Heusden are both situated in the municipality Asten, and therefore have the same pig density
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Table 2 Hepatitis E virus seroprevalence in the general population and potential determinants for HEV seropositivity
Determinants N Seroprevalence (%)a Crude ORb [95% CI]c Adjusted ORb,d,e [95% CI]c
Age (years)
20–30 50 10.0 Ref. Ref.
30–40 179 15.1 1.60 [0.58–4.39] 1.49 [0.54–4.13]
40–50 432 19.2 2.14 [0.82–5.55] 2.01 [0.77–5.26]
50–60 661 25.1 3.02 [1.18–7.72] 2.58 [1.00–6.70]
60–70 938 37.5 5.40 [2.13–13.73] 4.22 [1.63–10.91]
> =70 162 38.3 5.58 [2.10–14.80] 4.15 [1.53–11.24]
Gender
Female 1,318 25.6 Ref. Ref.
Male 1,104 32.3 1.39 [1.16–1.65] 1.21 [1.00–1.47]
Educational level
High 733 24.8 Ref. Ref.
Medium 1,080 26.9 1.12 [0.90–1.38] 1.10 [0.87–1.38]
Low 609 36.5 1.74 [1.37–2.20] 1.36 [1.04–1.76]
Diet without pork meat
No 2,360 28.8 Ref. Ref.
Yes 47 19.2 0.59 [0.28–1.22] 0.72 [0.33–1.59]
Missing 15
Ever smoked
No 1,034 26.5 Ref. Ref.
Yes 1,388 30.3 1.21 [1.01–1.45] 0.96 [0.79–1.17]
Childhood in study region
No 580 32.2 Ref. Ref.
Yes 1,816 27.4 0.79 [0.65–0.97] 0.85 [0.68–1.07]
Missing 26
Childhood on pig farm
No 1,928 27.6 Ref. Ref.
Yes 468 32.5 1.26 [1.02–1.57] 1.21 [0.94–1.55]
Missing 26
Performed jobs on farm during childhood
No 1,090 26.9 Ref. - Ref.
Yes 1,220 29.7 1.15 [0.96–1.38] 1.02 [0.83–1.27]
Missing 112
Number of pigs within 1000 m of residential address (tertiles)
Lowf 807 32.1 Ref. Ref.
Intermediateg 808 26.9 0.78 [0.63–0.96] 0.79 [0.63–0.99]
Highh 807 27.1 0.79 [0.64–0.98] 0.83 [0.66–1.04]
aIncluding both positive and borderline samples (anti-HEV IgG ratio > = 0.90)
bOdds Ratio
c95% Confidence Interval
dORs are adjusted for age, gender, educational level, diet without pork meat, ever smoked, childhood in study region, childhood on pig farm, jobs on farm during
childhood and number of pigs within 1000 m of residential address
eAdjusted ORs and 95% CIs were calculated for cases without missing answers (N = 2,301)
fNumber of pigs within 1000 m < = 1,003
gNumber of pigs within 1000 m > 1,003 and < = 5,771
hNumber of pigs within 1000 m > 5,771
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in a higher proportion of proven infections and it re-
mains positive for longer period post infection compared
with the MP assay [56, 58, 59, 63].
In line with other serological studies, we found statisti-
cally significant higher seroprevalence in participants
aged 50 years and older compared to 20–30 year olds
[18, 44, 57, 62, 64]. This higher seroprevalence in older
persons might be a result of age-dependent cumulative
exposure, but can also be indicative of an age-cohort be-
cause of higher pressure of infection in the past. This
age-cohort effect is also demonstrated in Denmark, the
United Kingdom and the United States [60, 61, 65]. The
HEV seroprevalence in blood donors as well as the high
number of HEV RNA-positive donors found in sero-
logical screenings suggest an increasing HEV incidence
in recent years in the Netherlands [18, 66, 67].
Proximity to pig farms and number of animals close to
the home were used as proxy of potential environmental
exposure to HEV. The lack of a positive association
suggests that airborne spread of HEV is unlikely. Other
environmental transmission routes cannot be excluded,
for example through manure that may be transported
to distant places or through surface water. In the
Netherlands, HEV RNA has been detected in surface
water samples [68]. Furthermore, a recent cross-sectional
study suggests that consumption of tap water in France
might be a risk factor for HEV infection [69]. Occupa-
tional exposure to pigs, which is a potential risk factor
for seropositivity, was not investigated in our study since
persons living or working on a farm were excluded
[44, 47, 70]. Moreover, the present study was not de-
signed to investigate the role of food-borne transmission.
Presence of IgG antibodies is an indicator for HEV infec-
tion in the past and therefore suited to study exposure to
HEV through the environment. Although we found no de-
creased risk for HEV seropositivity in participants who did
not consume pork meat, this finding must be interpreted
with caution because of the small numbers of participants
on a diet without pork meat (n = 47, 2.0%). Moreover,
some of these participants might have consumed pork
meat in the past. A case-control study focussing mainly on
food-borne transmission among patients with acute hepa-
titis E infection in the Netherlands is ongoing (study
period: 2015–2017).
Conclusions
In conclusion, our study showed that the HEV sero-
prevalence in the general population in a livestock-dense
area in the south of the Netherlands was not associated
with living in proximity to pig farms. The higher sero-
prevalence among older participants supports the assump-
tion of cumulative lifetime exposure to hepatitis E virus in
the Netherlands, as well as an age-cohort because of
higher pressure of infection in the past. Although it seems
plausible that transmission is primarily food-borne, further
research is needed to elucidate the exact sources and
routes of infection.
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